TAG:
histology lab
Ventana & Cytyc Fall Short, Danaher Wins the Prize
By Robert Michel | From the Volume XIII No. 15 – November 6, 2006 Issue
WHEN Danaher Corporation’s high bid for Vision Systems Limited of Melbourne, Australia, was accepted last month, it appeared to be simply another acquisition by a large U.S. manufacturer. But, in fact, there are four reasons this transaction is significant to patho…
Labs Taught Physicians How to Do TC/PC Deals
By Robert Michel | From the Volume XIII No. 9 – July 3, 2006 Issue
CEO SUMMARY: As many pathology groups discover that their best urology and gastroenterology clients are taking serious steps to do their own anatomic pathology, they ask a basic question: How did their best-referring…
Office-Based Docs Want Anatomic Path Revenues
By Robert Michel | From the Volume XIII No. 9 – July 3, 2006 Issue
CEO SUMMARY: Specialist physicians think they’ve found gold in anatomic pathology services. Indifferent regions of the United States, urologists and gastroenterologists are taking active steps to cut themselves a piece from the anatomic pathology revenue pie. Some physician groups are b…
Technical/Professional Billing Triggers Strong Opinions
By Robert Michel | From the Volume XIII No. 9 – July 3, 2006 Issue
IT’S A TREND WHICH IS GAINING THE NOTICE of growing numbers of pathologists. Physician groups are taking steps to directly engage pathologists to diagnose cases. The term “TC/PC” is often used to describe situations where two different providers provide the technical component…
Many Trends in AP Spell Lots of Change Ahead
By Robert Michel | From the Volume XIII No. 2 – February 6, 2006 Issue
CEO SUMMARY: Every second year, THE DARK REPORT releases its list of key trends in anatomic pathology. These trends help shape an understanding about the state of the pathology profession. Our current list includes 11 identifiable trends. This is not an auspicious sign for pathologists wh…
Failure of AD Pathlabs: Structural Weakness?
By Robert Michel | From the Volume XIII No. 1 – January 16, 2006 Issue
CEO SUMMARY: AD PathLabs is the latest in a string of business disappointments. Over the past decade, a number of anatomic pathology companies have proven that they can grow rapidly—attracting substantial volumes of specimens. But these companies seem to hit a financial wall that leads …
Bio-Reference Labs Develops Regional & Niche Strategies
By Robert Michel | From the Volume XII No. 14 – October 3, 2005 Issue
CEO SUMMARY: Bio-Reference Laboratories, Inc. (BRLI) of Elmwood Park, New Jersey is a lab company on a roll. In just five years, it has grown from $66 million to more than $160 million in annual revenues. For regional laboratories across the country, BRLI’s business strategies demon…
Bi-Annual Look at Trends Reshaping Clinical Labs
By Robert Michel | From the Volume XII No. 2 – January 24, 2005 Issue
CEO SUMMARY: Among other things, we declare the end to the heyday of the independent commercial lab company which offers a broad test menu to all types of office-based physicians. In its place springs forth the specialty or niche testing laboratory. Small and focused on a specific number …
Change Beneath Surface Marks 2004 Lab Stories
By Robert Michel | From the Volume XI No. 17 – December 13, 2004 Issue
CEO SUMMARY: Presented here are THE DARK REPORT’S “Ten Biggest Lab Stories of 2004.” These are the events we consider most important to the lab industry during the year. However, in contrast to past years, 2004 lacked the types of blockbuster events which radically change and reshap…
Pathology Consultants See In-House AP Trend Unfolding
By Robert Michel | From the Volume XI No. 11 – August 9, 2004 Issue
LOCAL PATHOLOGY GROUP PRACTICES are themselves the “canary in the coal mine” to provide early warning about the exploding interest of specialist physicians at capturing the anatomic pathology (AP) revenues generated by their patients. THE DARK REPORT interviewed three consultants, each of whom s…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized